L. Mueller

HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptides

R. Rees, G. Pawelec, F. Lemonnier, 2007, Cancer Immunology, Immunotherapy.

A novel MHC-associated Proteinase 3 peptide isolated from primary chronic myeloid leukaemia cells further supports the significance of this antigen for the immunotherapy of myeloid leukaemias

S. Stevanović, A. Weinzierl, G. Pawelec, 2006, Leukemia.

T cell epitope definition by differential mass spectrometry: Identification of a novel, immunogenic HLA‐B8 ligand directly from renal cancer tissue

H. Dihazi, H. Kalbacher, T. Flad, 2006, Proteomics.

Cancer Immunotherapy 2004: Mainz, Germany, 6–7 May 2004

G. Pawelec, C. Britten, A. Knights, 2004, Cancer Immunology, Immunotherapy.